• 1
    Thamm DH, Vail DM. Mast cell tumors. In: WithrowSJ, MacEwenEG, eds. Small Animal Clinical Oncology, 4rd ed. Philadelphia, PA: WB Saunders Co; 2007:402424.
  • 2
    Séguin B, Besancon MF, McCallan JL, et al. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994–2002). J Vet Intern Med 2006;20:933940.
  • 3
    Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutanous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: A retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38:458466.
  • 4
    Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor: 41 cases (1992–1997). J Vet Intern Med 1999;13:491497.
  • 5
    La Due T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol 1998;39:5762.
  • 6
    Spugnini EP, Dragonetti E, Vincenzi B, et al. Pulse mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 2006;16:2327.
  • 7
    Spugnini EP, Vincenzi B, Baldi F, et al. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res 2006;26:45854889.
  • 8
    Spugnini EP, Baldi F, Mellone P, et al. Patterns of tumor responses in canine and feline cancer dogs treated with electrochemotherapy. J Transl Med 2007;5:48.
  • 9
    Kodre V, Cemazar M, Pecar J, et al. Electrochemotherapy compared to surgery for the treatment of canine mast cell tumors. In Vivo 2009;23:5562.
  • 10
    Epstein E. Intralesional bleomycin and Raynaud's phenomenon. J Am Acad Dermatol 1991;24:785786.